Bridge Pharma was a privately held research and development company focusing exclusively on pharmaceutical projects with blockbuster potential.

These projects addressed unmet medical needs within large and growing global markets. Bridge Pharma’s projects offered new therapies with significant improvements and advantages over existing treatments.

The Company had several research projects with blockbuster potential and was acquired by Phramaron Holdings in early 2010.


VISIT WEBSITE Back to Portfolio